WHO issues its first Hepatitis B treatment guidelines
Health Organization has issued its firstever guidance for the treatment of chronic hepatitis B, which spreads through blood and body fluids, affects the liver and results in 650,000 deaths each year. "These new guidelines will help clinicians make the right decisions," says Stefan Wiktor, who leads WHO's Global Hepatitis Programme. Key recommendations include the use of a few simple non-invasive tests to assess the stage of liver disease; prioritising treatment for those with cirrhosis; the use of drugs tenofovir and entecavir for treating chronic hepatitis B; and regular monitoring for early detection of liver cancer.
COURTESY: WIKIMEDIA .ORG